focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Credit Suisse Upgrades Diageo To Outperform

Thu, 29th Oct 2015 09:40

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
CREDIT SUISSE RAISES DIAGEO TO 'OUTPERFORM' ('NEUTRAL') - PRICE TARGET 2100 (1780) PENCE
----------
LIBERUM CUTS RIO TINTO TO 'SELL' ('HOLD') - TARGET 1900 (2090) PENCE
----------
LIBERUM CUTS BHP BILLITON TO 'SELL' ('HOLD') - TARGET 900 (1045) PENCE
----------
EXANE BNP CUTS LLOYDS PRICE TARGET TO 78 (82) PENCE - 'NEUTRAL'
----------
UBS CUTS LLOYDS PRICE TARGET TO 97 (100) PENCE - 'BUY'
----------
JPMORGAN CUTS LLOYDS PRICE TARGET TO 98 (105) PENCE - 'OVERWEIGHT'
----------
SOCGEN CUTS LLOYDS PRICE TARGET TO 98 (100) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS LLOYDS PRICE TARGET TO 91 (96) PENCE - 'BUY'
----------
EXANE BNP CUTS MEGGITT PRICE TARGET TO 400 (500) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK CUTS MEGGITT PRICE TARGET TO 375 (500) PENCE - 'HOLD'
----------
Deutsche Bank Ups GlaxoSmithKline Price Target To 1,500p From 1,450p, Keeps Hold
----------
JPMORGAN CUTS WPP PRICE TARGET TO 1,785 (1,800) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS ANTOFAGASTA PRICE TARGET TO 530 (660) PENCE - 'NEUTRAL'
----------
S&P CAPITAL IQ CUTS ANTOFAGASTA TO 'STRONG SELL' ('SELL') - TARGET 410 (540) P
----------
DEUTSCHE BANK CUTS ANTOFAGASTA PRICE TARGET TO 610 (615) PENCE - 'HOLD'
----------
JEFFERIES RAISES SAINSBURY PRICE TARGET TO 280 (260) PENCE - 'HOLD'
----------
JEFFERIES RAISES NEXT PRICE TARGET TO 6750 (6000) PENCE - 'UNDERPERFORM'
----------
NOMURA CUTS PEARSON PRICE TARGET TO 1,050 (1,100) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE CUTS BAE SYSTEMS TO 'NEUTRAL' ('OUTPERFORM') - TARGET 460 (590) PENCE
----------
TRADERS: CITIGROUP RAISES CENTRICA TO 'BUY'
----------
BARCLAYS CUTS STANDARD LIFE PRICE TARGET TO 508 (523) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES BAT PRICE TARGET TO 4,050 (3,950) PENCE - 'OVERWEIGHT'
----------
MORGAN STANLEY RAISES BAT PRICE TARGET TO 3900 (3750) PENCE - 'EQUAL-WEIGHT'
----------
BARCLAYS CUTS ABERDEEN ASSET MANAGEMENT TARGET TO 350 (400) PENCE - 'EQUAL WEIGHT'
----------
BERENBERG CUTS SHIRE PRICE TARGET TO 6,000 (6,200) PENCE - 'BUY'
----------
SOCGEN CUTS MEGGITT PRICE TARGET TO 400 (495) PENCE - 'HOLD'
----------
S&P CAPITAL IQ RAISES BAT PRICE TARGET TO 4200 (3750) PENCE - 'HOLD'
----------
FTSE 250
----------
NUMIS CUTS WH SMITH TO 'REDUCE' ('HOLD') - TARGET 1500 PENCE
----------
Investec Lifts Booker Group Price Target To 210p From 205p, Keeps Buy
----------
Investec Initiates Shawbrook Group With Buy At 375p
----------
NOMURA INITIATES IG GROUP WITH 'BUY' - TARGET 850 PENCE
----------
GOLDMAN CUTS PETRA DIAMONDS PRICE TARGET TO 80 (160) PENCE - 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
LIBERUM RAISES TOPPS TILES PRICE TARGET TO 176 (160) PENCE - 'BUY'
----------
FinnCap Lifts Scientific Digital Imaging Price Target to 29p From 27p
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.